Bridgeway Capital Management’s IO Biotech IOBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Hold |
75,000
| – | – | ﹤0.01% | 1066 |
|
|
2025
Q1 | $81.8K | Sell |
75,000
-99,000
| -57% | -$108K | ﹤0.01% | 1072 |
|
|
2024
Q4 | $160K | Sell |
174,000
-25,623
| -13% | -$23.6K | ﹤0.01% | 1046 |
|
|
2024
Q3 | $210K | Buy |
199,623
+75,000
| +60% | +$78.8K | ﹤0.01% | 1056 |
|
|
2024
Q2 | $146K | Hold |
124,623
| – | – | ﹤0.01% | 1115 |
|
|
2024
Q1 | $218K | Sell |
124,623
-20,577
| -14% | -$36K | ﹤0.01% | 1097 |
|
|
2023
Q4 | $273K | Buy |
145,200
+13,000
| +10% | +$24.4K | 0.01% | 1076 |
|
|
2023
Q3 | $182K | Hold |
132,200
| – | – | ﹤0.01% | 1125 |
|
|
2023
Q2 | $259K | Hold |
132,200
| – | – | 0.01% | 1074 |
|
|
2023
Q1 | $247K | Hold |
132,200
| – | – | 0.01% | 1063 |
|
|
2022
Q4 | $304K | Buy |
132,200
+36,300
| +38% | +$83.5K | 0.01% | 987 |
|
|
2022
Q3 | $260K | Buy |
95,900
+20,900
| +28% | +$56.7K | 0.01% | 1080 |
|
|
2022
Q2 | $350K | Buy |
+75,000
| New | +$350K | 0.01% | 962 |
|